|
|
 |
|
|
New opportunities for active pharmaceutical ingredient industry by Ma tracy
|
|
|
New opportunities for active pharmaceutical ingredient industry by MA TRACY
|
|
| Article Posted: 01/10/2012 |
| Article Views: 97 |
| Articles Written: 1018 - MORE ARTICLES FROM THIS AUTHOR |
| Word Count: 438 |
| Article Votes: 0 |
|
New opportunities for active pharmaceutical ingredient industry |
|
|
|
|
|
Business,Marketing,Manufacturing
|
|
|
The output of Chinese active pharmaceutical ingredient reached 1.06 million tons in 2010 which ranks first in the world. The annual increasing rate is 8.05%. However, for some time in future, in the case of rising prices, and continue strengthen about environmental management, the industry's cost advantage will be no longer evidently. Chinese API industry has ushered in the best time to adjust. From 2010 to 2015, there are nearly 400 international patents on drugs expire, mainly in the respiratory system drugs, endocrine and metabolic drugs, cardiovascular drugs, central nervous system drugs, respiratory system, digestive system drugs and other medication and several major areas. API China 2010 exports also verified this trend, the export growth in the top ten drugs in addition to endocrine and metabolic drugs, other types of products are listed. Expired patent medicine, especially the ‘blockbuster’ drug patent expiration level, the development of bulk drug industry in China will provide new opportunities. In this opportunity, the API has a character is the largest enterprises can benefit from the basic conditions. So, how can the characteristics of their products as raw material medicine? For the trade, must have the characteristics of bulk drugs the following elements: 1 The pharmaceutical raw materials must be soon to reach the patents expire and on the world’s ‘blockbuster’ sales levels. 2 If the patent has not expired, manufacturers can avoid the patent must have the maturity of production technology; 3 Market in the countries where international norms for drug certification; 4 Certified manufacturer of bulk drugs formulations can be used to make preparations for its production and marketing application in Europe API source. Once the application is approved, pharmaceutical raw materials will become the fixed supplier, so as to maintain price stability. It should be noted that not all of these drugs in the country which obtain the approval number of the products are special bulk drugs, even if they are successfully exported through various channels. Even with international certification documents, but without preparation of the bulk drugs specified manufacturers into regulating the market is still very difficult. At present, China can be only regarded as API ‘production power’ rather than the production of power.’ Therefore, the country's industrial structure adjustment of industry will necessarily reflect on the development of bulk drugs glutathione .On the one hand it will increase research and development. On the other hand there will have on existing businesses regulation. In this process, inefficient and highly polluting enterprises will be merged, acquired or eliminated, and eventually several competitive large enterprises will be formed. Thereby it will increase the international competitiveness of Chinese pharmaceutical companies. Source:http://www.cospcn.com
Related Articles -
pharmaceutical raw materials, Glutathione, Resveratrol,
|
Rate This Article  |
|
|
|
|
|
Do you Agree or Disagree? Have a Comment? POST IT!
| Reader Opinions |
|
|
|
|
|
|
|
|
|
| Author Login |
|
|
 |
Advertiser Login
ADVERTISE HERE NOW!
Limited Time $60 Offer!
90 Days-1.5 Million Views
|
|
GENE MYERS
Author of four books and two screenplays; frequent magazine contributor. I have four other books "in...more
|
|
|
|
|
TIM FAY
After 60-plus years of living, I am just trying to pass down some of the information that I have lea...more
|
|
|
|
|
ADRIAN JOELE
I have been involved in nutrition and weight management for over 12 years and I like to share my kn...more
|
|
|
|
|
LAURA JEEVES
At LeadGenerators, we specialise in content-led Online Marketing Strategies for our clients in the t...more
|
|
|
|
|
STEPHEN BYE
Steve Bye is currently a fiction writer, who published his first novel, ‘Looking Forward Through the...more
|
|
|
|
|
ALEX BELSEY
I am the editor of QUAY Magazine, a B2B publication based in the South West of the UK. I am also the...more
|
|
|
|
|
SUSAN FRIESEN
Located in the lower mainland of B.C., Susan Friesen is a visionary brand strategist, entrepreneur, ...more
|
|
|
|
|
SHALINI MITTAL
A postgraduate in Fashion Technology. Shalini is a writer at heart! Writing for her is an expression...more
|
|
|
|
|
JAMES KENNY
James is a Research Enthusiast that focuses on the understanding of how things work and can be impro...more
|
|
|
|
